These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 22183139)

  • 1. Recurrence of macular edema associated with branch retinal vein occlusion after intravitreal bevacizumab.
    Hanada N; Iijima H; Sakurada Y; Imasawa M
    Jpn J Ophthalmol; 2012 Mar; 56(2):165-74. PubMed ID: 22183139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of macular edema due to branch retinal vein occlusion with single or multiple intravitreal injections of bevacizumab.
    Yunoki T; Miyakoshi A; Nakamura T; Fujita K; Fuchizawa C; Hayashi A
    Jpn J Ophthalmol; 2012 Mar; 56(2):159-64. PubMed ID: 22246387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravitreal injection of bevacizumab combined with macular grid laser photocoagulation for macular edema in branch retinal vein occlusion.
    Hayashi A; Yunoki T; Miyakoshi A; Mitarai K; Fujino T; Yanagisawa S
    Jpn J Ophthalmol; 2011 Nov; 55(6):625-31. PubMed ID: 21909658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.
    Ding X; Li J; Hu X; Yu S; Pan J; Tang S
    Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of injection of intravitreal drugs with standard care in macular edema secondary to branch retinal vein occlusion.
    Lee K; Jung H; Sohn J
    Korean J Ophthalmol; 2014 Feb; 28(1):19-25. PubMed ID: 24505197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective comparisons of intravitreal injections of triamcinolone acetonide and bevacizumab for macular oedema due to branch retinal vein occlusion.
    Higashiyama T; Sawada O; Kakinoki M; Sawada T; Kawamura H; Ohji M
    Acta Ophthalmol; 2013 Jun; 91(4):318-24. PubMed ID: 22132711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two-year outcomes of intravitreal bevacizumab therapy for macular oedema secondary to branch retinal vein occlusion.
    Hikichi T; Higuchi M; Matsushita T; Kosaka S; Matsushita R; Takami K; Ohtsuka H; Kitamei H; Shioya S
    Br J Ophthalmol; 2014 Feb; 98(2):195-9. PubMed ID: 24215032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravitreal bevacizumab and cytokine levels in major and macular branch retinal vein occlusion.
    Lim JW
    Ophthalmologica; 2011; 225(3):150-4. PubMed ID: 21150231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravitreal bevacizumab associated with grid laser photocoagulation in macular edema secondary to branch retinal vein occlusion.
    Salinas-Alamán A; Zarranz-Ventura J; Caire González-Jauregui JM; Sádaba-Echarri LM; Barrio-Barrio J; García-Layana A
    Eur J Ophthalmol; 2011; 21(4):434-9. PubMed ID: 21140369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in retinal blood flow in patients with macular edema secondary to branch retinal vein occlusion before and after intravitreal injection of bevacizumab.
    Nagaoka T; Sogawa K; Yoshida A
    Retina; 2014 Oct; 34(10):2037-43. PubMed ID: 24896136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined intravitreal bevacizumab and grid laser photocoagulation for macular edema secondary to branch retinal vein occlusion.
    Donati S; Barosi P; Bianchi M; Al Oum M; Azzolini C
    Eur J Ophthalmol; 2012; 22(4):607-14. PubMed ID: 22101497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravitreal bevacizumab vs. sham treatment in acute branch retinal vein occlusion with macular edema: results at 3 months (Report 1).
    Moradian S; Faghihi H; Sadeghi B; Piri N; Ahmadieh H; Soheilian M; Dehghan MH; Azarmina M; Esfahani MR
    Graefes Arch Clin Exp Ophthalmol; 2011 Feb; 249(2):193-200. PubMed ID: 21337043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravitreal triamcinolone acetonide versus bevacizumab therapy for macular edema associated with branch retinal vein occlusion.
    Byun YJ; Roh MI; Lee SC; Koh HJ
    Graefes Arch Clin Exp Ophthalmol; 2010 Jul; 248(7):963-71. PubMed ID: 20182882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Twenty-Four-Month Results of Intravitreal Bevacizumab in Macular Edema Secondary to Branch Retinal Vein Occlusion.
    Tsagkataki M; Papathomas T; Lythgoe D; Kamal A
    Semin Ophthalmol; 2015; 30(5-6):352-9. PubMed ID: 24875368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term follow-up of OCT-guided bevacizumab treatment of macular edema due to retinal vein occlusion.
    Hoeh AE; Ach T; Schaal KB; Scheuerle AF; Dithmar S
    Graefes Arch Clin Exp Ophthalmol; 2009 Dec; 247(12):1635-41. PubMed ID: 19633982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical bromfenac reduces the frequency of intravitreal bevacizumab in patients with branch retinal vein occlusion.
    Shimura M; Yasuda K
    Br J Ophthalmol; 2015 Feb; 99(2):215-9. PubMed ID: 25185254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bevacizumab treatment for acute branch retinal vein occlusion accompanied by subretinal hemorrhage.
    Zhao L; Li B; Feng K; Han L; Ma Z; Liu Y
    Curr Eye Res; 2015 Jul; 40(7):752-6. PubMed ID: 25330134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination therapy with intravitreal bevacizumab and macular grid and scatter laser photocoagulation in patients with macular edema secondary to branch retinal vein occlusion.
    Yang CS; Liu JH; Chung YC; Chou YB; Hung KH
    J Ocul Pharmacol Ther; 2015 Apr; 31(3):179-85. PubMed ID: 25715024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of intravitreal bevacizumab upload followed by a dexamethasone implant versus dexamethasone implant monotherapy for retinal vein occlusion with macular edema.
    Mayer WJ; Remy M; Wolf A; Kook D; Kampik A; Ulbig M; Reznicek L; Haritoglou C
    Ophthalmologica; 2012; 228(2):110-6. PubMed ID: 22739239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between optical coherence tomographic hyperreflective foci and visual outcomes after intravitreal bevacizumab for macular edema in branch retinal vein occlusion.
    Kang JW; Lee H; Chung H; Kim HC
    Graefes Arch Clin Exp Ophthalmol; 2014 Sep; 252(9):1413-21. PubMed ID: 24577742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.